(Q44646770)

5 December 2017

A retrospective analysis of the effect of noncompliance on time to first major adverse cardiac event in LIPS. (English)

1 reference

5 December 2017

3

1 reference

5 December 2017

1

Emmanuel Lesaffre

1 reference

5 December 2017

5

Patrick W Serruys

1 reference

5 December 2017

Dora Kocmanová

2

1 reference

PubMed ID

14604742

5 December 2017

Clemens M C Disco

series ordinal

4

1 reference

5 December 2017

1 September 2003

1 reference

5 December 2017

Clinical Therapeutics

1 reference

5 December 2017

25

1 reference

5 December 2017

9

1 reference

5 December 2017

2431-2447

1 reference

The Lescol ® Intervention Prevention Study (LIPS): a double-blind, placebo-controlled, randomized trial of the long-term effects of fluvastatin after successful transcatheter therapy in patients with coronary heart disease

5 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980285-0

7 January 2021

Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980285-0

7 January 2021

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980285-0

7 January 2021

Compliance with cardiovascular disease prevention strategies: a review of the research

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980285-0

7 January 2021

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980285-0

7 January 2021

A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980285-0

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980285-0

7 January 2021

Withdrawal of statins increases event rates in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980285-0

7 January 2021

Adherence with statin therapy in elderly patients with and without acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980285-0

7 January 2021

Efficacy and tolerability of fluvastatin extended-release delivery system: a pooled analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980285-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980285-0

1 reference

7 January 2021

10.1016/S0149-2918(03)80285-0

Identifiers

DOI

1 reference

5 December 2017

1 reference

PubMed ID

14604742